ArticleThrombosis journal2018

COSIMO - patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thromboembolism: a non-interventional study.

Alexander T Cohen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.